Quan Capital

Quan Capital

Quan Capital

$70,000,000 Venture capital (Series B)
PE Hub , FinSMEs

Crescendo Biologics rakes in $70 mln Series B

Messaging
$70,000,000 Venture capital (Series B)
PE Hub

Tempest Therapeutics hauls in $70 mln Series B

Messaging
Xconomy

Tempest Therapeutics Debuts with $70M to Bring Cancer Drugs to Clinic

Health Funding
FinSMEs

resTORbio Announces Initial Public Offering Pricing

Costs Stock markets Health
$67,000,000 Venture capital (Series D)
MedCity News

Centrexion's $67M Series D round to fund Phase 3 pain studies

$11,160,000 Convertible Note
venturedeal , sec

Centrexion Therapeutics Nets Venture Capital Debt

Funding